Study Stopped
Halted Prematurely
Early Psychological Intervention to Prevent Cardiovascular Event-Induced PTSD (REACH Sub-study)
Written Exposure Therapy to Prevent PTSD in Survivors of Acute Cardiovascular Events: A Pilot Randomized Clinical Trial
1 other identifier
interventional
10
1 country
1
Brief Summary
The overall purpose of this project is to determine the feasibility of conducting a randomized clinical trial that compares written exposure therapy with usual care among patients at risk for cardiovascular event-induced PTSD. Patients hospitalized with acute cardiovascular events, including strokes, heart attacks, and cardiac arrest are at risk of developing post-traumatic stress disorder (PTSD) due to the trauma of the acute medical event. The goal of this study is to test the feasibility of conducting a randomized trial involving a psychological intervention to prevent the development of PTSD symptoms in patients at risk for PTSD. Patients who are admitted with these acute cardiovascular events will first be screened for PTSD risk factors while in-hospital after the index event. These risk factors will include elevated threat perceptions at the time of presentation to the hospital or early symptoms of PTSD due to the cardiovascular event. Patients at elevated risk for PTSD will then be randomized to the intervention group or usual care. Those assigned to the intervention will participate in 5 sessions of written exposure therapy in which they are asked to write about the experience of their cardiovascular event with guidance from a trained study clinician. At 1 month after discharge, all patients will be contacted by phone to complete a questionnaire that assesses PTSD symptoms related to the cardiovascular event. Descriptive statistics will be used to understand the feasibility of testing the written exposure therapy intervention as part of a larger, fully powered clinical trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2018
CompletedFirst Posted
Study publicly available on registry
July 30, 2018
CompletedStudy Start
First participant enrolled
August 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 14, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedResults Posted
Study results publicly available
August 26, 2020
CompletedSeptember 16, 2020
August 1, 2020
1 year
July 20, 2018
July 29, 2020
August 28, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
PTSD Checklist - Stressor Specific (PCL-S) Score
This is to measure PTSD symptoms due to the index cardiovascular event. The PCL-S is self-report measure of the symptoms of PTSD. Respondents rate how much they were bothered by 20 symptoms, each rated on a 5-point scale ranging from 0 (not at all) to 4 (extremely), such that total scores range from 0-80. The PCL-S (specific stressor) asks respondents about symptoms in relation to an identified stressful experience. The PCL-S aims to link symptom endorsements to the index cardiovascular event
1 month after hospital discharge
Secondary Outcomes (4)
Number of Subjects Completing the Written Exposure Therapy
Approximately 1 month after hospital discharge
Adherent to Cardiovascular Medications
Approximately 1 month after hospital discharge
PHQ-8 Score
Baseline, 1 month after hospital discharge
Short Form Health Survey Version 2.0 (SF-12v2) Score
Approximately 6 months after hospital discharge
Study Arms (2)
Early Psychological Intervention
ACTIVE COMPARATORThose assigned to Early Psychological Intervention will receive Written Exposure Therapy, a 5 session treatment in which participants write about their trauma event in a specified manner.
Usual care
NO INTERVENTIONThose assigned to usual care will complete study assessments but will not be referred to any psychological treatment
Interventions
Written exposure therapy is a 5 session treatment in which participants write about their trauma event in a specified manner.
Eligibility Criteria
You may qualify if:
- Hospitalized with acute stroke, TIA, ACS, or cardiac arrest
- Enrolled in REACH-stroke, PHS, or REACH-cardiac arrest observational cohort studies
- Elevated ASD symptoms (ASD score \>=28) and/or elevated threat perceptions during index hospitalization (ED threat score \>=12)
You may not qualify if:
- Unavailable for follow-up for written exposure therapy sessions
- Unable to read and write in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- National Center for PTSDcollaborator
Study Sites (1)
Center for Behavioral Cardiovascular Health
New York, New York, 10032, United States
Related Publications (1)
Sloan DM, Marx BP, Lee DJ, Resick PA. A Brief Exposure-Based Treatment vs Cognitive Processing Therapy for Posttraumatic Stress Disorder: A Randomized Noninferiority Clinical Trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-239. doi: 10.1001/jamapsychiatry.2017.4249.
PMID: 29344631BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Ian Kronish
- Organization
- Center for Behavioral Cardiovascular Health, Columbia University Irving Medical Center
Study Officials
- STUDY DIRECTOR
Ian Kronish, MD
Associate Professor of Medicine, Dept of Med Beh Cardiology
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcomes assessors that assess PTSD symptoms 1 month after discharge (primary outcome) will be blinded to treatment assignment.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine, Dept of Med Beh Cardiology
Study Record Dates
First Submitted
July 20, 2018
First Posted
July 30, 2018
Study Start
August 1, 2018
Primary Completion
August 14, 2019
Study Completion
December 31, 2019
Last Updated
September 16, 2020
Results First Posted
August 26, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will become available August 1, 2020, and will be available until August 1, 2025.
- Access Criteria
- For whom: Researchers who provide a methodologically sound protocol. For what analyses: To achieve aims in the approved protocol.
De-identified data will be made available upon request to the study prinicipal investigator.